Abstract
Hypertension in children is a common and serious problem associated with target organ damage including left ventricular hypertrophy (LVH), increased carotid intima-media thickness (CIMT), and microalbuminuria. Unfortunately, there is ample evidence that the problem goes unrecognized in clinical practice. There are multiple reasons for this including the complexity of blood pressure standards in children, a lack of knowledge among clinicians, skepticism about the importance of hypertension in children, conflicting screening recommendations, and discomfort among clinicians, patients, and families with pharmacotherapy. Strategies to improve rates of diagnosis include clinical decision support systems, educational programs, and incorporating diagnosis and management of hypertension into a broader strategy to address weight and lifestyle among overweight and obese children. Furthermore, evidence about the long-term impact of hypertension in children is emerging and should motivate improved screening, diagnosis, and management according to established guidelines.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blumenthal S, Epps RP, Heavenrich R et al. Report of the task force on blood pressure control in children. Pediatrics. 1977;59(suppl 2): I-II, 797–820.
Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298(8):874–9.
Brady TM, Solomon BS, Neu AM, SIberry GK, Parekh RS. Patient, provider, and clinic-level predictors of unrecognized elevated BP in children. Pediatrics. 2010;125(6):e1286–93.
Riley M, Dobson M, Sen A, Green L. Recognizing elevated BP in children and adolescents: how are we doing. J Fam Pract. 2013;62(6):294–9.
Chen X, Wang Y. Tracking of BP from childhood to adulthood. Circulation. 2008;117(25):3171–80.
Shapiro DJ, Hersh AL, Cabana MD, Sutherland SM, Patel AI. Hypertension screening during ambulatory pediatric visits in the United States, 2000–2009. Pediatrics. 2012;130(4):604–10.
Parker ED, Sinaiko AR, Daley MF, et al. Factors associated with adherence to blood pressure measurement recommendations at pediatric primary care visits, Minnesota and Colorado, 2007–2010. Prev Chronic Dis. 2015;12:E118.
Stabouli S, Sideras L, Vareta G, et al. Hypertension screening during healthcare pediatric visits. J Hypertens. 2015;33(5):1064–8.
Rabbia F, Testa E, Rabbia S, et al. Effectiveness of a BP educational and evaluation program for the improvement of measurement accuracy among nurses. High Blood Press Cardiovasc Prev. 2013;20(2):77–80.
Armstrong RS. Nurses’ knowledge of error in BP measurement technique. Int J Nurse Pract. 2002;8(3):118–26.
Arafat M, Mattoo TK. Measurement of BP in children. Recommendations and perceptions on cuff selection. Pediatrics. 1999;104:e30.
Project ECHO. http://echo.unm.edu/. Accessed 28 Aug 2016.
ECHO Chicago. http://www.echo-chicago.org/. Accessed 28 Aug 2016.
Gupta-Malhotra M, Banker A, Shete S, et al. Essential hypertension vs secondary hypertension among children. Am J Hypertens. 2015;28(1):73–80.
Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117(25):3171–80.
Daniels SR, Loggie JMH, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97(19):1907–11.
Juhola J, Magnussen CG, Berenson GS, et al. Combined effects of child and adult eleveated blood pressure on subclinical atherosclerosis: the Internation Childhood Cardiovascular Consortium. Circulation. 2013;128(3):217–24.
Matteucci MC, Chinali M, Rinelli G, ESCAPE Trial Group, et al. Change in cardiac geometry and function in CKD children during strict BP control: a randomized study. Clin J Am Soc Nephrol. 2013;8(2):203–10.
Litwin M, Niemirska A, Sladowska-Kozlowska J, et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol. 2010;25(12):2489–99.
Moyer VA, US Preventive Services Task Force. Screening for primary hypertension in children and adolescents: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159(9):613–9.
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents; summary report. Pediatrics. 2011;128 suppl 5:S213–56.
Dwyer T, Sun C, Magnussen CG, et al. Cohort profile: the international childhood cardiovascular cohort (i3c) consortium. Int J Epidemiol. 2013;42(1):86–96.
Rao G. Diagnosis, epidemiology, and management of hypertension in children. Pediatrics. 2016;138(2):e20153616.
Mamudu HM, Paul TK, Veeranki SP, Budoff M. The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review. Atherosclerosis. 2014;236(2):338–50.
Acknowledgments
This paper was supported by grant R21HS024100-01 Improving Diagnosis of Hypertension in Children (G. Rao, Principal Investigator) from the Agency for Healthcare Research and Quality (AHRQ).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
Dr. Rao has no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain studies with human or animal subjects performed by the author.
Rights and permissions
About this article
Cite this article
Rao, G. Hypertension in Children: Motivating Improvement in Clinical Practice. Curr Cardiovasc Risk Rep 10, 42 (2016). https://doi.org/10.1007/s12170-016-0521-6
Published:
DOI: https://doi.org/10.1007/s12170-016-0521-6